{"id":266,"date":"2018-05-17T17:45:17","date_gmt":"2018-05-17T17:45:17","guid":{"rendered":"http:\/\/www.montclair.edu\/forward-thinking\/?page_id=266"},"modified":"2018-05-29T14:23:43","modified_gmt":"2018-05-29T14:23:43","slug":"when-the-research-is-personal","status":"publish","type":"page","link":"https:\/\/www.montclair.edu\/forward-thinking\/spring-2018\/when-the-research-is-personal\/","title":{"rendered":"When the Research Is Personal"},"content":{"rendered":"

Like any researcher, Assistant Professor of Nutrition and Food Studies Mousumi Bose was thrilled to receive an extension of a National Institutes of Health\u2013 funded training grant from the Sterol and Isoprenoid Research (STAIR) Consortium of the Rare Diseases Clinical Research Network.<\/p>\n

Unlike most researchers, however, Bose uses her work to celebrate the life of a son she lost far too soon.<\/p>\n

Bose was a postdoctoral fellow at Columbia University when she became pregnant with her first son, Ilan, who was born in August 2010 with Zellweger Spectrum Disorder (ZSD), a rare metabolic illness that affects one in 50,000 children.<\/p>\n

Bose was 37 weeks pregnant with her second son, Etash, when Ilan died. \u201cIlan had round-the-clock seizures, low muscle tone and was constantly on oxygen,\u201d she says. \u201cI didn\u2019t know how long he would be with us, so I quit my job and cared for him. He passed away in October 2011.\u201d<\/p>\n

“I have the opportunity to contribute to a better understanding of these kids and make a difference for every family touched by ZSD.”<\/p>\n